tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Alibaba upgraded, Rivian downgraded: Wall Street’s top analyst calls
The FlyAlibaba upgraded, Rivian downgraded: Wall Street’s top analyst calls
16d ago
BYD
CAG
Agios Pharmaceuticals initiated with a Buy at H.C. Wainwright
PremiumThe Fly
Agios Pharmaceuticals initiated with a Buy at H.C. Wainwright
16d ago
AGIO
Agios Pharmaceuticals price target lowered to $74 from $75 at Scotiabank
PremiumThe Fly
Agios Pharmaceuticals price target lowered to $74 from $75 at Scotiabank
26d ago
AGIO
Agios Pharmaceuticals Reports Strong 2024 Financial Results
PremiumCompany Announcements
Agios Pharmaceuticals Reports Strong 2024 Financial Results
27d ago
AGIO
Agios Pharmaceuticals Earnings Call Highlights Growth & Pipeline Progress
PremiumCompany Announcements
Agios Pharmaceuticals Earnings Call Highlights Growth & Pipeline Progress
27d ago
AGIO
Agios Pharma: Promising Growth with Strategic Market Expansion and Pipeline Advancements
PremiumRatingsAgios Pharma: Promising Growth with Strategic Market Expansion and Pipeline Advancements
27d ago
AGIO
Agios Pharmaceuticals reports Q4 revenue $10.7M, consensus $9.35M
Premium
The Fly
Agios Pharmaceuticals reports Q4 revenue $10.7M, consensus $9.35M
27d ago
AGIO
Agios Pharmaceuticals reports results from Phase 3 ACTIVATE-Kids study
Premium
The Fly
Agios Pharmaceuticals reports results from Phase 3 ACTIVATE-Kids study
27d ago
AGIO
Agios Pharma Board Member Announces Resignation
PremiumCompany Announcements
Agios Pharma Board Member Announces Resignation
27d ago
8K
AGIO
Agios Pharmaceuticals price target lowered to $54 from $55 at BofA
PremiumThe Fly
Agios Pharmaceuticals price target lowered to $54 from $55 at BofA
29d ago
AGIO
AGIO Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
AGIO Upcoming Earnings Report: What to Expect?
29d ago
AGIO
Agios Pharma Sets Milestones for Rare Disease Growth
PremiumCompany Announcements
Agios Pharma Sets Milestones for Rare Disease Growth
2M ago
8K
AGIO
Agios Pharmaceuticals announces key 2025 milestones, catalysts through 2026
PremiumThe FlyAgios Pharmaceuticals announces key 2025 milestones, catalysts through 2026
2M ago
AGIO
Agios Pharmaceuticals announces FDA accepted sNDA for PYRUKYND
Premium
The Fly
Agios Pharmaceuticals announces FDA accepted sNDA for PYRUKYND
2M ago
AGIO
Agios Pharmaceuticals price target lowered to $55 from $60 at BofA
Premium
The Fly
Agios Pharmaceuticals price target lowered to $55 from $60 at BofA
2M ago
AGIO
Agios Pharmaceuticals announces EC adopted positive decision for mitapivat
PremiumThe Fly
Agios Pharmaceuticals announces EC adopted positive decision for mitapivat
3M ago
AGIO
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
KOD
AGIO
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
KOD
AGIO
Agios Pharmaceuticals price target raised to $75 from $53 at Scotiabank
PremiumThe Fly
Agios Pharmaceuticals price target raised to $75 from $53 at Scotiabank
3M ago
AGIO
Agios presents results from Phase 3 ENERGIZE-T Study of Mitapivat
PremiumThe FlyAgios presents results from Phase 3 ENERGIZE-T Study of Mitapivat
3M ago
AGIO
Agios Pharmaceuticals to present new data on mitapivat, tebapivat
Premium
The Fly
Agios Pharmaceuticals to present new data on mitapivat, tebapivat
4M ago
AGIO
Agios Pharmaceuticals price target raised to $53 from $51 at Scotiabank
Premium
The Fly
Agios Pharmaceuticals price target raised to $53 from $51 at Scotiabank
4M ago
AGIO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >